In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Moleculin Biotech Inc (NASDAQ: MBRX) closed at $0.58 down -12.46% from its previous closing price of $0.67. In other words, the price has decreased by -$12.46 from its previous closing price. On the day, 1.29 million shares were traded. MBRX stock price reached its highest trading level at $0.714 during the session, while it also had its lowest trading level at $0.5501.
Ratios:
For a deeper understanding of Moleculin Biotech Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 11.25 whereas as Long-Term Debt/Eq ratio is at 8.25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MBRX now has a Market Capitalization of 8236332 and an Enterprise Value of 970329.
Stock Price History:
The Beta on a monthly basis for MBRX is 1.56, which has changed by -0.8457672 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, MBRX has reached a high of $4.71, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is -34.30%, while the 200-Day Moving Average is calculated to be -65.37%.
Shares Statistics:
For the past three months, MBRX has traded an average of 601.18K shares per day and 715610 over the past ten days. A total of 14.13M shares are outstanding, with a floating share count of 14.01M. Insiders hold about 0.84% of the company’s shares, while institutions hold 10.46% stake in the company. Shares short for MBRX as of 1748563200 were 602992 with a Short Ratio of 1.00, compared to 1745971200 on 725045. Therefore, it implies a Short% of Shares Outstanding of 602992 and a Short% of Float of 4.3.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
